Penicillamine Tablet, Film Coated
Product Images NDC 0254-2000

3 FDA label images from Par Health Usa, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Penicillamine (NDC 0254-2000). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Par Health Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical-structure (Penicillamine Tablets Usp 1)

Chemical-structure (Penicillamine Tablets Usp 1)
Chemical structure of penicillamine showing its molecular connectivity with functional groups including thiol (HS), methyl (CH3), amino (NH2), and carboxyl (COOH) groups.*
FDA Label Image

Formula (Penicillamine Tablets Usp 2)

Formula (Penicillamine Tablets Usp 2)
Chemical equations depicting reversible thiol-disulfide exchange reactions between CSSC, PS', CS', PSSP, and CSSP species, illustrating redox interactions possibly relevant to penicillamine's biochemical mechanism.*
FDA Label Image

Penicillamine Tablets (Penicillamine Tablets Usp 3)

Penicillamine Tablets (Penicillamine Tablets Usp 3)
Label for Penicillamine Tablets, USP 250 mg film-coated tablets, oral use. The label indicates a package size of 100 tablets, distributed by Par Pharmaceutical and manufactured by Par Formulations Private Limited in India. It provides storage instructions and a note to see the package circular for full prescribing information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.